甲状腺癌特异性效用指数:甲状腺癌生活质量指数的开发与赋值
本研究通过多中心、多阶段混合方法开发了甲状腺癌特异性效用测量工具TCQOLI,最终采用9个维度,心理测量学稳健,与直接VAS相关性好(r≈0.74-0.75),ICC为0.74,适用于健康经济学评价。
要点
- TCQOLI为甲状腺癌特异性、基于偏好的效用测量工具,含9个维度。
- 量表天花板效应低(3.8%),无地板效应,心理测量学表现稳健。
- 9维加法多属性效用指数与直接VAS相关性最佳(r≈0.74-0.75)。
核心结论
- TCQOLI是心理测量学稳健的甲状腺癌特异性偏好测量工具,适用于健康经济学评价。
研究设计与样本
- 多中心、多阶段、混合方法、横断面研究;阶段1由多学科专家和患者定义维度与条目;阶段2通过认知访谈(n=50)和心理测量调查(n=163)评估工具并进行验证性因子分析和信效度分析;阶段3在独立样本(n=103)中使用访谈者施测的视觉模拟量表(VAS;0-100)和标准博弈法(SG)对健康状态进行赋值。
主要发现
- 最终确定10个候选维度,因生殖担忧维度心理测量学最弱且模型权重最低,主要工具采用9个维度(也评估了10维版本)。
- 验证性因子分析支持一般健康相关生活质量因子加声音/吞咽因子,复合信度和模型拟合可接受。
- 量表水平天花板效应低(3.8%),无地板效应。
- 9维加法多属性效用理论指数与直接VAS相关(r≈0.74-0.75),一致性最佳。
- 经SG映射后MAE/OSD为0.045/0.095,ICC为0.74(良好至优秀)。
关键数值与推荐
- 主要工具采用9个维度(10维版本也评估)。
- 天花板效应3.8%,无地板效应。
- 9维加法指数与直接VAS的r≈0.74-0.75。
- SG映射后MAE/OSD为0.045/0.095,ICC为0.74。
临床怎么用
- TCQOLI可用于甲状腺癌的临床研究、成本效果分析和政策应用中的质量调整生命年估计。
- 该简明指数支持甲状腺癌的比较效果研究,并可为临床和政策环境中的资源分配提供信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thyroid cancer survivors experience distinctive, persistent burdens that diminish health-related quality of life (HRQoL). Utilities from patient preference-based measures are needed for quality-adjusted life-year estimation and decision-making. Generic instruments lack thyroid-specific content, limiting applicability in this population. We sought to develop a thyroid-cancer-specific utility measure, Thyroid Cancer Quality of Life Index (TCQOLI) to support clinical research, cost-effectiveness analyses, and policy applications. METHODS: We conducted a multicenter, multiphase, mixed-method, cross-sectional study. Phase 1 defined the TCQOLI domains and items using input from multidisciplinary experts and patients with thyroid cancer. Phase 2 evaluated the instrument via cognitive interviews (n = 50) and a mailed/phone-assisted psychometric survey in adults with thyroid cancer (n = 163), followed by confirmatory factor analysis (CFA) and reliability/validity analyses. Phase 3 valued health states in a separate sample (n = 103) using interviewer-administered visual analog scales (VAS; 0-100) and standard gamble (SG). Levels of morbidity in each health domain with VAS and SG were used for assessing preferences for three clinical marker states. We derived a weighted dead-to-full-health lower VAS anchor, estimated a VAS to SG power mapping solution to apply to the model overall, and constructed additive, multiplicative, and unweighted indices. Agreement of the indices with direct VAS was summarized by Pearson r, mean absolute error (MAE), overall standard deviation (OSD) of differences, and intraclass correlation (ICC). RESULTS: Ten candidate domains were finalized; because one domain, reproduction concern, had the weakest psychometrics and the lowest model weight, the primary instrument uses nine domains (a 10-domain version was also evaluated). CFA supported a general HRQoL factor plus a voice/swallow factor with acceptable composite reliability and model fit. The instrument-level ceiling effect was low (3.8%) with no floor effect. The 9-domain additive multiattribute utility theory index correlated with direct VAS (r ≈ 0.74-0.75) and showed the best agreement. MAE/OSD was 0.045/0.095 after SG mapping and a good to excellent ICC of 0.74. CONCLUSIONS: TCQOLI is a psychometrically robust, thyroid-cancer-specific, preference-based measure with patient-anchored valuation, suitable for health-economic evaluations. This concise index supports comparative-effectiveness research in thyroid cancer and informs resource allocation across clinical and policy settings.
引用
- Cunningham CE, van Dijk S, Langer MM, et al. A Thyroid-Cancer-Specific Utility Index: Development and Valuation of the Thyroid Cancer Quality of Life Index. Thyroid. 2026. PMID: 41735804. doi:10.1177/10507256261425624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。